These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 32480097)

  • 21. Patterns of interstitial lung disease and mortality in rheumatoid arthritis.
    Zamora-Legoff JA; Krause ML; Crowson CS; Ryu JH; Matteson EL
    Rheumatology (Oxford); 2017 Mar; 56(3):344-350. PubMed ID: 27940586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics--a large multicentre UK study.
    Kelly CA; Saravanan V; Nisar M; Arthanari S; Woodhead FA; Price-Forbes AN; Dawson J; Sathi N; Ahmad Y; Koduri G; Young A;
    Rheumatology (Oxford); 2014 Sep; 53(9):1676-82. PubMed ID: 24758887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of rheumatoid arthritis diagnoses in health care utilization data.
    Kim SY; Servi A; Polinski JM; Mogun H; Weinblatt ME; Katz JN; Solomon DH
    Arthritis Res Ther; 2011 Feb; 13(1):R32. PubMed ID: 21345216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Design and Rationale of the Trail1 Trial: A Randomized Double-Blind Phase 2 Clinical Trial of Pirfenidone in Rheumatoid Arthritis-Associated Interstitial Lung Disease.
    Solomon JJ; Danoff SK; Goldberg HJ; Woodhead F; Kolb M; Chambers DC; DiFranco D; Spino C; Haynes-Harp S; Hurwitz S; Peters EB; Dellaripa PF; Rosas IO;
    Adv Ther; 2019 Nov; 36(11):3279-3287. PubMed ID: 31515704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validation of serostatus of rheumatoid arthritis using ICD-10 codes in administrative claims data.
    Lee H; Sparks JA; Lee SB; Yoshida K; Landon JE; Kim SC
    Pharmacoepidemiol Drug Saf; 2023 May; 32(5):586-591. PubMed ID: 36728737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of rheumatoid arthritis patients using an administrative database: a Veterans Affairs study.
    Ng B; Aslam F; Petersen NJ; Yu HJ; Suarez-Almazor ME
    Arthritis Care Res (Hoboken); 2012 Oct; 64(10):1490-6. PubMed ID: 22623324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rheumatoid Arthritis Disease Activity Predicting Incident Clinically Apparent Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Prospective Cohort Study.
    Sparks JA; He X; Huang J; Fletcher EA; Zaccardelli A; Friedlander HM; Gill RR; Hatabu H; Nishino M; Murphy DJ; Iannaccone CK; Mahmoud TG; Frits ML; Lu B; Rosas IO; Dellaripa PF; Weinblatt ME; Karlson EW; Shadick NA; Doyle TJ
    Arthritis Rheumatol; 2019 Sep; 71(9):1472-1482. PubMed ID: 30951251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rheumatoid arthritis-associated interstitial lung disease: an overview of epidemiology, pathogenesis and management.
    Dai Y; Wang W; Yu Y; Hu S
    Clin Rheumatol; 2021 Apr; 40(4):1211-1220. PubMed ID: 32794076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Biological Disease-modifying Anti-rheumatic Drugs on Airway and Interstitial Lung Disease in Patients with Rheumatoid Arthritis.
    Kurata I; Tsuboi H; Terasaki M; Shimizu M; Toko H; Honda F; Ohyama A; Yagishita M; Osada A; Ebe H; Kawaguchi H; Takahashi H; Hagiwara S; Asashima H; Kondo Y; Matsumoto I; Sumida T
    Intern Med; 2019 Jun; 58(12):1703-1712. PubMed ID: 30799358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biomarkers of rheumatoid arthritis-associated interstitial lung disease.
    Chen J; Doyle TJ; Liu Y; Aggarwal R; Wang X; Shi Y; Ge SX; Huang H; Lin Q; Liu W; Cai Y; Koontz D; Fuhrman CR; Golzarri MF; Liu Y; Hatabu H; Nishino M; Araki T; Dellaripa PF; Oddis CV; Rosas IO; Ascherman DP
    Arthritis Rheumatol; 2015 Jan; 67(1):28-38. PubMed ID: 25302945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of a Methodologic Approach to Define an Inception Cohort of Rheumatoid Arthritis Patients Using Administrative Data.
    Curtis JR; Xie F; Chen L; Greenberg JD; Zhang J
    Arthritis Care Res (Hoboken); 2018 Oct; 70(10):1541-1545. PubMed ID: 29409118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The serum level and significance of lysyl oxidase-like 2 in patients with rheumatoid arthritis-associated interstitial lung disease.
    Fu Q; Bai Y; Liu Y; Zhou J; Zheng Y
    Clin Rheumatol; 2018 Jan; 37(1):193-198. PubMed ID: 29052023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improving risk-stratification of rheumatoid arthritis patients for interstitial lung disease.
    Avouac J; Cauvet A; Steelandt A; Shirai Y; Elhai M; Kuwana M; Distler O; Allanore Y
    PLoS One; 2020; 15(5):e0232978. PubMed ID: 32384128
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of risk factors of mortality in rheumatoid arthritis patients with interstitial lung disease: a nationwide, population-based cohort study in Taiwan.
    Ng KH; Chen DY; Lin CH; Chao WC; Chen HH
    RMD Open; 2022 Aug; 8(2):. PubMed ID: 35995491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of interstitial lung disease on mortality of patients with rheumatoid arthritis.
    Kim D; Cho SK; Choi CB; Choe JY; Chung WT; Hong SJ; Jun JB; Jung YO; Kim TH; Kim TJ; Lee HS; Lee JH; Lee J; Lee SS; Yoo DH; Yoon BY; Song JW; Bae SC; Sung YK
    Rheumatol Int; 2017 Oct; 37(10):1735-1745. PubMed ID: 28748423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An administrative data validation study of the accuracy of algorithms for identifying rheumatoid arthritis: the influence of the reference standard on algorithm performance.
    Widdifield J; Bombardier C; Bernatsky S; Paterson JM; Green D; Young J; Ivers N; Butt DA; Jaakkimainen RL; Thorne JC; Tu K
    BMC Musculoskelet Disord; 2014 Jun; 15():216. PubMed ID: 24956925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rheumatoid arthritis-related interstitial lung disease (RA-ILD): methotrexate and the severity of lung disease are associated to prognosis.
    Rojas-Serrano J; Herrera-Bringas D; Pérez-Román DI; Pérez-Dorame R; Mateos-Toledo H; Mejía M
    Clin Rheumatol; 2017 Jul; 36(7):1493-1500. PubMed ID: 28585060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A preliminary study of lung abnormalities on HRCT in patients of rheumatoid arthritis-associated interstitial lung disease with progressive fibrosis.
    Li L; Gao S; Fu Q; Liu R; Zhang Y; Dong X; Li Y; Li M; Zheng Y
    Clin Rheumatol; 2019 Nov; 38(11):3169-3178. PubMed ID: 31302858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of diagnostic coding for interstitial lung diseases in an electronic health record system in Hong Kong.
    Ye Y; Hubbard R; Li GH; Ho SC; Sing CW; Cheung CL; Lam DCL
    Pharmacoepidemiol Drug Saf; 2022 May; 31(5):519-523. PubMed ID: 35218107
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical characteristics of rheumatoid arthritis patients with interstitial lung disease: baseline data of a single-center prospective cohort.
    Kim H; Cho SK; Song YJ; Kang J; Jeong SA; Kim HW; Choi CB; Kim TH; Jun JB; Bae SC; Yoo DH; Lee H; Park DW; Sohn JW; Yoon HJ; Hong SJ; Yoo SJ; Choi YW; Lee Y; Kim SH; Sung YK
    Arthritis Res Ther; 2023 Mar; 25(1):43. PubMed ID: 36932433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.